Biotech RadarJobs updated

COMPANY

Helicore Biopharma

helicore.com ↗

Clinical Phase 1

Keywords: antibody metabolic obesity Obesity and Overweight HCR-188

Profile checked Oct 10, 2026

1Trials (company is sponsor)

Timeline

  1. Trial start Early phase 1: A First-in-human Study of HCR-188 in Overweight or Obese Otherwise Healthy Volunteers Without Type 2 Diabetes source ↗

Clinical trials (lead sponsor) 1

RecordTitlePhaseStatusStartPrimary completion
NCT06845943A First-in-human Study of HCR-188 in Overweight or Obese Otherwise Healthy Volunteers Without Type 2 DiabetesEarly phase 1SuspendedMar 4, 2025Oct 22, 2025 (actual)

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

Feedback